Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Leslie Hanrahan"'
Autor:
N. Bello, Laure Delbecque, Diane L. Kamen, Anca Askanase, Leslie Hanrahan, Julie Birt, Nashmel Sargalo, Kirstin Griffing, M Hadi, Paul Swinburn, Karin Tse, Maria E. Silk, Ella Brookes
Publikováno v:
Rheumatology and Therapy
Objectives To provide information on systemic lupus erythematosus (SLE) patients’ experiences, satisfaction, and expectations with treatments and examine the association between treatment satisfaction and patient-reported outcomes (PRO). Methods A
Publikováno v:
Therapeutic Innovation & Regulatory Science. 54:1159-1165
Due to the extreme heterogeneity of lupus and the lack of consensus among stakeholders, pharmaceutical and biotechnology companies have had limited success in developing treatments for lupus. For this reason, the Lupus Foundation of America (LFA), re
Autor:
Sandra Raymond, Joan M. Von Feldt, Laura E. Schanberg, Timothy Franson, Bradley Dickerson, Kenneth A. Getz, Amy H. Kao, Sanjyot Sangodkar, Victoria P. Werth, Kenneth C. Kalunian, Kathleen Arntsen, Leslie Hanrahan, Sang Cheol Bae, David Zook, Thomas Dörner, Erin Connolly-Strong, Lauren Bloch, Ian N. Bruce, Eric F Morand, Susan Manzi, Karen H. Costenbader, Brad H. Rovin, Sydney Evans, Karin Tse, Yaritza Peña, Angel Williams Derricott
Publikováno v:
Lupus Science & Medicine
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
The Addressing Lupus Pillars for Health Advancement (ALPHA) Project is a global consensus effort to identify, prioritise and address top barriers in lupus impacting diagnosis, care, treatment and research. To conduct this process, the ALPHA Project c
Autor:
Diane L. Kamen, Karen H. Costenbader, Samantha C. Nguyen, Leslie Hanrahan, Mimi Y. Kim, Aikaterini Thanou-Stavraki, Anca D. Askanase, Joan T. Merrill, S. Sam Lim, Cynthia Aranow, Jennifer M. Grossman, De Anna Baker-Frost, Teresa Aberle, Teja Kapoor
Publikováno v:
Arthritis Care & Research. 70:1058-1063
Lupus disease measures such as the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and the British Isles Lupus Assessment Group (BILAG) index are challenging to interpret. The Lupus Foundation of America-Rapid Evaluation of Activity in L
Autor:
Jinoos Yazdany, Alexa Meara, Liana Fraenkel, W. Winn Chatham, Jasvinder A. Singh, Laura Marrow, Elyse Reyes, Candace Green, Leslie Hanrahan, Kenneth G. Saag, Jennifer L. Barton, Brennda Caro, Nipam Shah, Tara Rizvi, Sandra Raymond, Amye Leong, Robert P. Kimberly, Graciela S. Alarcón, Richard L. Street, Maria E. Suarez-Almazor, Jeff A. Sloan, Charity J. Morgan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e47092744fe9c5e28312996072e3c897
https://doi.org/10.25302/10.2019.ce.13046631
https://doi.org/10.25302/10.2019.ce.13046631
Autor:
Candace Green, Kenneth G. Saag, Tara Rizvi, Jennifer M. Grossman, Brennda Caro, Liana Fraenkel, Laura Marrow, Elyse Reyes, Jinoos Yazdany, Richard L. Street, W. Winn Chatham, Maria Dall’Era, Leslie Hanrahan, Jennifer L. Barton, Charity J. Morgan, Bochra Jandali, Guy Eakin, Amye Leong, Salvador Garcia, Robert P. Kimberly, Sandra Raymond, Jasvinder A. Singh, Alexa Meara, Graciela S. Alarcón, Kevin L. Winthrop, Jeff A. Sloan, Laura Trupin, Maria E. Suarez-Almazor
Publikováno v:
Poster Presentations.
Background Medication decision-making is challenging in lupus. No validated, effective decision-aids are available to assist patients with medication decision-making. Objectives Our objective was to assess the effectiveness of an individualized, cult
Autor:
Guy Eakin, Jeff A. Sloan, Alexa Meara, Leslie Hanrahan, Jennifer L. Barton, Maria Dall'Era, Salvador Garcia, Kevin L. Winthrop, Bochra Jandali, Tara Rizvi, Candace Green, Jasvinder A. Singh, Elyse Reyes, Sandra Raymond, Charity J. Morgan, Jennifer M. Grossman, Liana Fraenkel, Kenneth G. Saag, Jinoos Yazdany, W. Winn Chatham, Graciela S. Alarcón, Brennda Caro, Laura Marrow, Laura Trupin, Robert P. Kimberly, Richard L. Street, Maria E. Suarez-Almazor, Amye L. Leong
Publikováno v:
PLoS medicine, vol 16, iss 5
PLoS Medicine, Vol 16, Iss 5, p e1002800 (2019)
PLoS Medicine
PLoS Medicine, Vol 16, Iss 5, p e1002800 (2019)
PLoS Medicine
Background Treatment decision-making regarding immunosuppressive therapy is challenging for individuals with lupus. We assessed the effectiveness of a decision aid for immunosuppressive therapy in lupus nephritis. Methods and findings In a United Sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::204f8bcac97064553f332c44c4edb476
https://escholarship.org/uc/item/5xx5c1r8
https://escholarship.org/uc/item/5xx5c1r8
Publikováno v:
Lupus Science & Medicine
The majority of patients with SLE in the USA have been prescribed hydroxychloroquine (HCQ). Given more recent guidelines, the availability of only one strength (200 mg tablets) may limit the flexibility and ability to accurately dose patients with lu
Autor:
Leslie Hanrahan, E. Brookes, Diane L. Kamen, N. Sargalo, M. Hadi, N. Bello Vega, P. Swinburn, M. Silk, Julie Birt, Kirstin Griffing, L. Delbecque, Karin Tse
Publikováno v:
Annals of the Rheumatic Diseases. 79:353.2-354
Background:Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory condition impacting multiple organ systems.1,2SLE affects approximately 1.5 million Americans, disproportionately females of reproductive age, and is more prevalent in
Publikováno v:
Annals of the Rheumatic Diseases. 79:1916-1916
Background:Fatigue is one of the most common symptoms reported by patients with systemic lupus erythematosus (SLE)—it is responsible for considerable loss of work time and greatly impaired quality of life. The Functional Assessment of Chronic Illne